Company intelligence / Profile preview

Neural Labs Africa

Nairobi, Nairobi, Kenyaunicefventurefund.org ↗

Ownership: Private
Development stage: Commercial

Overview

Neural Labs Africa has developed and clinically tested its AI-driven medical imaging platform NeuralSight™, which can identify over 20 respiratory and cardiac pathologies from X-rays in real time. Clinical trials have been conducted in Kenya and Senegal to validate sensitivity and specificity. The solution is being piloted with hospital partners to further refine performance before broader commercialization.

Therapeutic areas: OncologyPulmonologyCardiovascularInfectious Diseases
Modalities: Device (AI-based diagnostic software)Non-pharmacological therapy (medical imaging analysis)
Industry: Medical Imaging

Partnerships

UNICEF Venture FundQualcomm Make in Africa Startup Mentorship ProgramVillgro Africa's AI for Health programHospital chain partner(s) in Senegal/Kenya for clinical validation

Beyond the preview

Go deeper on Neural Labs Africa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neural Labs Africa.

Explore the full profile